{
    "Trade/Device Name(s)": [
        "QuantRx Female Fertility Test",
        "QuantRx\u2122 Female Fertility Test"
    ],
    "Submitter Information": "QuantRx Biomedical Corporation",
    "510(k) Number": "K070484",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032002",
        "K010556",
        "K041165",
        "K893976"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "NGA"
    ],
    "Summary Letter Date": "September 23, 2007",
    "Summary Letter Received Date": "September 26, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1300"
    ],
    "Regulation Name(s)": [
        "Follicle-stimulating hormone test system"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Follicle-stimulating hormone (FSH)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup",
        "Device absorbent tip (direct urine application)"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral-flow immunoassay"
    ],
    "Methodologies": [
        "Rapid immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for QuantRx Female Fertility Test, an OTC lateral-flow immunoassay for urine FSH to assess ovarian reserve",
    "Indications for Use Summary": "Measures follicle-stimulating hormone (FSH) in urine as an ancillary fertility screen for home use by women attempting to conceive",
    "fda_folder": "Clinical Chemistry"
}